By Dr Hester Hannah Katherine Wilson

Journal articles

Selamoglu M; Erbas B; Wilson H; Barton C, 2024, '‘Why do we have to be the gatekeepers?’ Australian general practitioners’ knowledge, attitudes and prescribing intentions on e-cigarettes as a smoking cessation aid', BMC Primary Care, 25, http://dx.doi.org/10.1186/s12875-024-02292-w

Wilson H; Harris-Roxas B; Lintzeris N; Harris MF, 2024, 'Diagnosing and managing prescription opioid use disorder in patients prescribed opioids for chronic pain in Australian general practice settings: a qualitative study using the theory of Planned Behaviour', BMC Primary Care, 25, pp. 236 - 236, http://dx.doi.org/10.1186/s12875-024-02474-6

Wilson HH; Zwar N, 2024, 'Assisting young people aged 12-25 years to cease e-cigarette use in general practice', Australian Journal of General Practice, 53, pp. 311 - 316, http://dx.doi.org/10.31128/AJGP-11-23-7021

Wilson HHK; Gainsbury SM, 2023, 'Behavioural addictions Problem gambling in general practice: How can we help?', Australian Journal of General Practice, 52, pp. 289 - 294, http://dx.doi.org/10.31128/AJGP-06-22-6472

Wilson H; Harris-Roxas B; Lintzeris N; Harris M, 2022, 'Diagnosing and managing patients with chronic pain who develop prescription opioid use disorder: A scoping review of general practitioners’ experience', Australian Journal of General Practice, 51, pp. 804 - 811, http://dx.doi.org/10.31128/AJGP-10-21-6201

Wilson HHK; Hargreaves A, 2022, 'Real-time prescription monitoring How it can help safe prescribing of high-risk medicines', Medicine Today, 23, pp. 63 - 69

Andrada E; Rodriguez M; Bandalan JH; Dangelo-Kemp D; Johnston L; Wilson H, 2022, 'Retention rates with monthly depot buprenorphine in general practice in Melbourne, Australia', Australian Journal of General Practice, 51, pp. 447 - 451, http://dx.doi.org/10.31128/AJGP-07-21-6098

Wilson HHK; Schulz M; Mills L; Lintzeris N, 2022, 'Feasibility and outcomes of a general practice and specialist alcohol and other drug collaborative care program in Sydney, Australia', Australian Journal of Primary Health, 28, pp. 158 - 163, http://dx.doi.org/10.1071/PY20197

Wilson H; Hall J; Harris-Roxas B, 2022, 'What do General Practitioners want from Specialist Alcohol and Other Drugs Services? A Qualitative Study of NSW Metropolitan GPs', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13463

Wilson H; Schulz M; Rodgers C; Lintzeris N; Hall J; Harris-Roxas B, 2022, 'What do General Practitioners want from Specialist Alcohol and Other Drugs Services? A Qualitative Study of NSW Metropolitan GPs', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13463

Oakley B; Wilson H; Hayes V; Lintzeris N, 2021, 'Managing opioid withdrawal precipitated by buprenorphine with buprenorphine', Drug and Alcohol Review, 40, pp. 567 - 571, http://dx.doi.org/10.1111/dar.13228

Wilson H, 2021, 'The challenges of managing both chronic pain and opioid use in general practice', Medical Journal of Australia, 214, pp. 416 - 417, http://dx.doi.org/10.5694/mja2.51041

Wilson H, 2021, 'Letters', Australian Journal of General Practice, 50, pp. 7 - 8

Wilson HHK; Norris R; Tapley A; Magin P; Klein L, 2021, 'Role legitimacy, comfort and confidence providing tobacco, alcohol and other drug care: a cross-sectional study of Australian early-career general practitioners', Education for Primary Care, 32, pp. 19 - 26, http://dx.doi.org/10.1080/14739879.2020.1830720

Wilson HHK; Armstrong F; Thong IG, 2020, 'Opioid prescribing: What do the 2020 PBS changes mean for GPs?', Medicine Today, 21, pp. 21 - 28

Lintzeris N; Wilson H, 2020, 'Take-home intranasal naloxone to prevent opioid overdose deaths', Medicine Today, 21, pp. 45 - 49, https://medicinetoday.com.au/2020/april/regular-series/take-home-intranasal-naloxone-prevent-opioid-overdose-deaths

Wilson H, 2020, 'How stigmatising language affects people in Australia who use tobacco, alcohol and other drugs', Australian Journal of General Practice, 49, pp. 155 - 158, http://dx.doi.org/10.31128/AJGP-07-19-4998

Wilson H, 2018, 'Stigmatising language', AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 47, pp. 742 - 742, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000456317700003&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Nielsen S; Reynolds A; Wilson H; Clark N, 2018, 'Codeine rescheduling and the GP', Medicine Today, 19, pp. 17 - 26

Wilson H, 2018, 'A man taking large codeine doses who wants to cease: A buprenorphine–naloxone taper', Medicine Today, 19, pp. 33 - 34

Lloyd-Jones M; Wilce H, 2004, 'Withdrawal of temazepam gelcaps', Australian Prescriber, 27, pp. 109 - 113, http://dx.doi.org/10.18773/austprescr.2004.089

Wilce H, 2004, 'Temazepam capsules: what was the problem?', Australian Prescriber, 27, pp. 58 - 59, http://dx.doi.org/10.18773/austprescr.2004.053

Back to profile page